The European Green Deal, adopted in December 2019, is the European Union’s ambitious roadmap to transform Europe into the first climate-neutral continent by 2050.
It’s a bold response to the climate crisis, emphasising sustainable growth, reduced environmental impact, and economic competitiveness. The comprehensive plan spans multiple sectors, addressing climate change, energy efficiency, and biodiversity while fostering a just transition to a greener economy.
To operationalise its vision, the EU has introduced several directives and regulations. In our 5-minute guide below, our Founder Jörg Dogwiler and Head of Regulatory Bruno Gretler summarise the Green Deal’s overarching objectives, the key directives for MedTech companies that underpin the Deal, and the implications for Swiss medical device manufacturers.
Do you have a sustainability challenge related to a medical device? Feel free to get in touch with our experts to start the conversation.
And stay tuned for our upcoming trio of topical articles that will delve further into the directives most relevant to MedTech companies in the context of the EU Green Deal, exploring their objectives, requirements, and challenges posed, as well as our advice on implementation and compliance strategy.
